Lv2
120 积分 2024-04-26 加入
Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial
1个月前
已完结
Artificial intelligence in therapeutic antibody design: Advances and future prospects
2个月前
已完结
Anti-IL-4R-JAKi antibody-drug conjugate effectively reduces IgE levels and inflammatory cell infiltration in Atopic Dermatitis
4个月前
已完结
Preclinical Development of GR2002, a Novel Anti-TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects
5个月前
已完结
Dual-epitope targeting of TSLP to simultaneously block TSLPR and IL-7Ralpha with a Biparatopic nanobody
7个月前
已完结
The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis
8个月前
已完结
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
8个月前
已完结
OX40, OX40L and Autoimmunity: a Comprehensive Review
8个月前
已完结
Asthma and Participation: A Scoping Review
9个月前
已完结
Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes
9个月前
已完结
皖公网安备34019202002308
